Spangler lab <\/u><\/a>focuses on combining structural biophysics, molecular engineering, and translational immunology to engineer antibodies that can be used as targeted therapeutics. His current focus is on the treatment of autoimmune diseases, such as diabetes, Crohn\u2019s disease, ulcerative colitis, and multiple sclerosis. This research has broad translational impacts and aims to overcome the drawbacks of current therapies and significantly improve quality of life for patients.<\/p>\n![\"\"](\"https:\/\/engineering.jhu.edu\/chembe\/wp-content\/uploads\/2021\/08\/Philippe-Baron_Headshot5-150x150.jpg\")
Philippe Baron<\/strong> was named as an ARCS\/MWC UG Scholar. His undergraduate research in the Bevan lab <\/u><\/a>focuses on understanding how to form highly ordered nanostructures without any topological defects. The goal is to produce photonic materials that can interact with light in a controlled way. This ability makes them useful in many products, e.g., improving solar cells that will help combat climate change, or developing color-changing consumer products such as coatings.<\/p>\n","protected":false},"template":"","class_list":["post-33209","news","type-news","status-publish","hentry","news_categories-awards-and-honors"],"acf":[],"yoast_head":"\nDerek van Dyke and Philippe Baron win ARCS\/MWC Scholar awards - Department of Chemical and Biomolecular Engineering<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Derek van Dyke and Philippe Baron win ARCS\/MWC Scholar awards - Department of Chemical and Biomolecular Engineering\" \/>\n<meta property=\"og:description\" content=\"Two ChemBE Hopkins students, Derek van Dyke and Philippe Baron have won ARCS Foundation Metropolitan Washington Chapter (MWC) Scholar awards for 2021 for their contributions to advance science. ARCS\/MWC supports…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Chemical and Biomolecular Engineering\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-10T14:00:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/engineering.jhu.edu\/chembe\/wp-content\/uploads\/2021\/08\/VanDyke_Headshot-150x150.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Derek van Dyke and Philippe Baron win ARCS\/MWC Scholar awards - Department of Chemical and Biomolecular Engineering","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/","og_locale":"en_US","og_type":"article","og_title":"Derek van Dyke and Philippe Baron win ARCS\/MWC Scholar awards - Department of Chemical and Biomolecular Engineering","og_description":"Two ChemBE Hopkins students, Derek van Dyke and Philippe Baron have won ARCS Foundation Metropolitan Washington Chapter (MWC) Scholar awards for 2021 for their contributions to advance science. ARCS\/MWC supports…","og_url":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/","og_site_name":"Department of Chemical and Biomolecular Engineering","article_modified_time":"2021-08-10T14:00:11+00:00","og_image":[{"url":"https:\/\/engineering.jhu.edu\/chembe\/wp-content\/uploads\/2021\/08\/VanDyke_Headshot-150x150.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/","url":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/","name":"Derek van Dyke and Philippe Baron win ARCS\/MWC Scholar awards - Department of Chemical and Biomolecular Engineering","isPartOf":{"@id":"https:\/\/engineering.jhu.edu\/chembe\/#website"},"primaryImageOfPage":{"@id":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/#primaryimage"},"image":{"@id":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/#primaryimage"},"thumbnailUrl":"https:\/\/engineering.jhu.edu\/chembe\/wp-content\/uploads\/2021\/08\/VanDyke_Headshot-150x150.jpg","datePublished":"2021-06-24T19:15:10+00:00","dateModified":"2021-08-10T14:00:11+00:00","breadcrumb":{"@id":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/#primaryimage","url":"https:\/\/engineering.jhu.edu\/chembe\/wp-content\/uploads\/2021\/08\/VanDyke_Headshot.jpg","contentUrl":"https:\/\/engineering.jhu.edu\/chembe\/wp-content\/uploads\/2021\/08\/VanDyke_Headshot.jpg","width":2032,"height":2400},{"@type":"BreadcrumbList","@id":"https:\/\/engineering.jhu.edu\/chembe\/news\/derek-van-dyke-and-philippe-baron-win-arcs-mwc-scholar-awards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/engineering.jhu.edu\/chembe\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/engineering.jhu.edu\/chembe\/news\/"},{"@type":"ListItem","position":3,"name":"Derek van Dyke and Philippe Baron win ARCS\/MWC Scholar awards"}]},{"@type":"WebSite","@id":"https:\/\/engineering.jhu.edu\/chembe\/#website","url":"https:\/\/engineering.jhu.edu\/chembe\/","name":"Department of Chemical and Biomolecular Engineering","description":"Department of Chemical and Biomolecular Engineering","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/engineering.jhu.edu\/chembe\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Department of Chemical and Biomolecular Engineering","distributor_original_site_url":"https:\/\/engineering.jhu.edu\/chembe","push-errors":false,"_links":{"self":[{"href":"https:\/\/engineering.jhu.edu\/chembe\/wp-json\/wp\/v2\/news\/33209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/engineering.jhu.edu\/chembe\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/engineering.jhu.edu\/chembe\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/engineering.jhu.edu\/chembe\/wp-json\/wp\/v2\/media?parent=33209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"https:\/\/engineering.jhu.edu\/chembe\/wp-content\/uploads\/2021\/08\/VanDyke_Headshot-150x150.jpg\")
Derek van Dyke<\/strong> was named as an ARCS\/MWC PhD Scholar. His Ph.D. research in the Spangler lab <\/u><\/a>focuses on combining structural biophysics, molecular engineering, and translational immunology to engineer antibodies that can be used as targeted therapeutics. His current focus is on the treatment of autoimmune diseases, such as diabetes, Crohn\u2019s disease, ulcerative colitis, and multiple sclerosis. This research has broad translational impacts and aims to overcome the drawbacks of current therapies and significantly improve quality of life for patients.<\/p>\n